Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Viewpoint Molecular Targeting

Viewpoint Molecular Targeting
2008 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$600K LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of pharmaceutical drugs intended for diagnostic imaging and therapy for cancer, with a focus on metastatic melanoma. The company's product can be used to determine the location and extent of cancerous tumors in the body, enabling the health professionals to direct a lethal dose of radiation precisely to cancer cells in the body.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 2500 Crosspark Boulevard
  • Coralville, IA 52241
  • United States

+1 (865) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Viewpoint Molecular Targeting’s full profile, request a free trial.

Viewpoint Molecular Targeting Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 19-Feb-2019 $600K 00000 Completed Pre-Clinical Trials
2. Grant 08-Sep-2017 000 Completed Pre-Clinical Trials
1. Grant 31-Aug-2016 $1.2M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Viewpoint Molecular Targeting Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Cancer Institute Government 000 0000 000000 0
Iowa Economic Development Authority Government 000 0000 000000 0
NIH Small Business Innovation Research Government 000 0000 000000 0

Viewpoint Molecular Targeting Executive Team (3)

Name Title Board
Seat
Contact
Info
Heyward Coleman Board Member and Chief Executive Officer
Michael Schultz Ph.D Co-Founder, Board Member and Chief Science Officer
Frances Johnson MD Co-Founder, Board Member and Chief Medical Officer

Viewpoint Molecular Targeting Board Members (4)

Name Representing Role Since Contact
Info
Curtis Nelson Viewpoint Molecular Targeting Board Member 000 0000
Frances Johnson MD Viewpoint Molecular Targeting Co-Founder, Board Member and Chief Medical Officer 000 0000
Heyward Coleman Viewpoint Molecular Targeting Board Member and Chief Executive Officer 000 0000
Michael Schultz Ph.D Viewpoint Molecular Targeting Co-Founder, Board Member and Chief Science Officer 000 0000